STAT+: At major cardiology conference, Wegovy’s the word
STAT
SEPTEMBER 2, 2024
LONDON — When Europe’s largest cardiology conference opened here this past Friday, one of the first sessions centered entirely on a single drug. It cut the risk of complications from a common form of heart failure, researchers reported. It helped improve the structure of the heart as well as its function. It even saved the lives of people with Covid-19 — a respiratory infection of all things.
Let's personalize your content